These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation. Nasr R; Guillemin MC; Ferhi O; Soilihi H; Peres L; Berthier C; Rousselot P; Robledo-Sarmiento M; Lallemand-Breitenbach V; Gourmel B; Vitoux D; Pandolfi PP; Rochette-Egly C; Zhu J; de Thé H Nat Med; 2008 Dec; 14(12):1333-42. PubMed ID: 19029980 [TBL] [Abstract][Full Text] [Related]
6. PML-RARA can increase hematopoietic self-renewal without causing a myeloproliferative disease in mice. Welch JS; Yuan W; Ley TJ J Clin Invest; 2011 Apr; 121(4):1636-45. PubMed ID: 21364283 [TBL] [Abstract][Full Text] [Related]
7. Clearance of PML/RARA-bound promoters suffice to initiate APL differentiation. Vitaliano-Prunier A; Halftermeyer J; Ablain J; de Reynies A; Peres L; Le Bras M; Metzger D; de Thé H Blood; 2014 Dec; 124(25):3772-80. PubMed ID: 25258343 [TBL] [Abstract][Full Text] [Related]
8. Synergy against PML-RARa: targeting transcription, proteolysis, differentiation, and self-renewal in acute promyelocytic leukemia. Dos Santos GA; Kats L; Pandolfi PP J Exp Med; 2013 Dec; 210(13):2793-802. PubMed ID: 24344243 [TBL] [Abstract][Full Text] [Related]
9. Identification of a novel TNRC18-RARA fusion in acute promyelocytic leukemia lacking t(15;17)(q24;q12)/PML-RARA. Wang Z; Wen L; Zhang L; Xu X; Chen X; Yao L; Wang M; Shen Z; Mo G; Wang Y; Zhao D; Cai W; Shen J; Chi X; Xu Y; Zeng Z; Pan J; Ruan C; Wu D; Jia Z; Chen S Mol Carcinog; 2021 Feb; 60(2):. PubMed ID: 33428799 [TBL] [Abstract][Full Text] [Related]
10. Tumor suppressor function of Gata2 in acute promyelocytic leukemia. Katerndahl CDS; Rogers ORS; Day RB; Cai MA; Rooney TP; Helton NM; Hoock M; Ramakrishnan SM; Nonavinkere Srivatsan S; Wartman LD; Miller CA; Ley TJ Blood; 2021 Sep; 138(13):1148-1161. PubMed ID: 34125173 [TBL] [Abstract][Full Text] [Related]
11. Notch signaling maintains proliferation and survival of the HL60 human promyelocytic leukemia cell line and promotes the phosphorylation of the Rb protein. Li GH; Fan YZ; Liu XW; Zhang BF; Yin DD; He F; Huang SY; Kang ZJ; Xu H; Liu Q; Wu YL; Niu XL; Zhang L; Liu L; Hao MW; Han H; Liang YM Mol Cell Biochem; 2010 Jul; 340(1-2):7-14. PubMed ID: 20157766 [TBL] [Abstract][Full Text] [Related]
12. Dll1- and dll4-mediated notch signaling are required for homeostasis of intestinal stem cells. Pellegrinet L; Rodilla V; Liu Z; Chen S; Koch U; Espinosa L; Kaestner KH; Kopan R; Lewis J; Radtke F Gastroenterology; 2011 Apr; 140(4):1230-1240.e1-7. PubMed ID: 21238454 [TBL] [Abstract][Full Text] [Related]
13. Identification of IRF8 as a potent tumor suppressor in murine acute promyelocytic leukemia. Gaillard C; Surianarayanan S; Bentley T; Warr MR; Fitch B; Geng H; Passegué E; de Thé H; Kogan SC Blood Adv; 2018 Oct; 2(19):2462-2466. PubMed ID: 30266821 [TBL] [Abstract][Full Text] [Related]
14. MIR125B1 represses the degradation of the PML-RARA oncoprotein by an autophagy-lysosomal pathway in acute promyelocytic leukemia. Zeng CW; Chen ZH; Zhang XJ; Han BW; Lin KY; Li XJ; Wei PP; Zhang H; Li Y; Chen YQ Autophagy; 2014 Oct; 10(10):1726-37. PubMed ID: 25126724 [TBL] [Abstract][Full Text] [Related]
15. In vitro response to all-trans retinoic acid of acute promyelocytic leukemias with nonreciprocal PML/RARA or RARA/PML fusion genes. Mozziconacci MJ; Liberatore C; Brunel V; Grignani F; Arnoulet C; Ferrucci PF; Fernandez F; Sainty D; Pelicci PG; Birg F; Lafage-Pochitaloff M Genes Chromosomes Cancer; 1998 Jul; 22(3):241-50. PubMed ID: 9624536 [TBL] [Abstract][Full Text] [Related]
16. Suppression of renal cell carcinoma growth by inhibition of Notch signaling in vitro and in vivo. Sjölund J; Johansson M; Manna S; Norin C; Pietras A; Beckman S; Nilsson E; Ljungberg B; Axelson H J Clin Invest; 2008 Jan; 118(1):217-28. PubMed ID: 18079963 [TBL] [Abstract][Full Text] [Related]
17. No evidence for a functional role of bi-directional Notch signaling during angiogenesis. Liebler SS; Feldner A; Adam MG; Korff T; Augustin HG; Fischer A PLoS One; 2012; 7(12):e53074. PubMed ID: 23300864 [TBL] [Abstract][Full Text] [Related]
18. PML/RARalpha and FLT3-ITD induce an APL-like disease in a mouse model. Kelly LM; Kutok JL; Williams IR; Boulton CL; Amaral SM; Curley DP; Ley TJ; Gilliland DG Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8283-8. PubMed ID: 12060771 [TBL] [Abstract][Full Text] [Related]
19. ΔNp73 overexpression promotes resistance to apoptosis but does not cooperate with PML/RARA in the induction of an APL-leukemic phenotype. Lucena-Araujo AR; Coelho-Silva JL; Pereira-Martins DA; Thomé C; Scheucher PS; Lange AP; Paiva HH; Hemmelgarn BT; Morais-Sobral MC; Azevedo EA; Franca-Neto PL; Franca RF; Silva CL; Krause A; Rego EM Oncotarget; 2017 Jan; 8(5):8475-8483. PubMed ID: 28035072 [TBL] [Abstract][Full Text] [Related]
20. Establishment of a humanized APL model via the transplantation of PML-RARA-transduced human common myeloid progenitors into immunodeficient mice. Matsushita H; Yahata T; Sheng Y; Nakamura Y; Muguruma Y; Matsuzawa H; Tanaka M; Hayashi H; Sato T; Damdinsuren A; Onizuka M; Ito M; Miyachi H; Pandolfi PP; Ando K PLoS One; 2014; 9(11):e111082. PubMed ID: 25369030 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]